Angiogenesis with biomaterial-based drug- and cell-delivery systems

  title={Angiogenesis with biomaterial-based drug- and cell-delivery systems},
  author={Zarana S. Patel and A. Mikos},
  journal={Journal of Biomaterials Science, Polymer Edition},
  pages={701 - 726}
  • Zarana S. Patel, A. Mikos
  • Published 2004
  • Medicine, Materials Science
  • Journal of Biomaterials Science, Polymer Edition
  • Angiogenesis, the formation of new blood vessels from existing ones, is an important event in several biological processes, including wound healing. It plays a key role in determining the final functionality and integration of any implanted medical device. In addition, angiogenesis is a required event for organ development and has been accepted as a rate-limiting step in engineering tissue replacements. Besides these regenerative processes, uncontrolled angiogenesis is also involved in a number… CONTINUE READING
    135 Citations
    Review paper: Critical Issues in Tissue Engineering: Biomaterials, Cell Sources, Angiogenesis, and Drug Delivery Systems
    • 214
    Induction of angiogenesis in tissue-engineered scaffolds designed for bone repair: A combined gene therapy–cell transplantation approach
    • 174
    • PDF
    Enhanced angiogenesis of porous collagen scaffolds by incorporation of TMC/DNA complexes encoding vascular endothelial growth factor.
    • 59
    • PDF
    Naturally derived materials-based cell and drug delivery systems in skin regeneration.
    • S. Huang, Xiaobing Fu
    • Medicine, Chemistry
    • Journal of controlled release : official journal of the Controlled Release Society
    • 2010
    • 240
    Customizable biomaterials as tools for advanced anti-angiogenic drug discovery.
    • 1
    The role of mechanical stresses in angiogenesis.
    • 89
    • PDF


    Systems for therapeutic angiogenesis in tissue engineering
    • 175
    Angiogenesis around new AB-polymer networks after one week of implantation in mice.
    • 13
    Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery.
    • 502
    Fibrin-based biomaterials to deliver human growth factors.
    • 183
    In vitro model of a vascular stroma for the engineering of vascularized tissues.
    • 88
    Regulation of angiogenesis and matrix remodeling by localized, matrix-mediated antisense gene delivery.
    • 58
    Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants.
    • 57